Neurocognitive effects of the hepatitis C virus

Current Hepatitis Reports

Volumn 8, Issue SUPPL. 1, 2009, Pages 18-26

  Posada, Carolina ^a   Morgan, Erin E ^a   Moore, David J ^a   Woods, Steven Paul ^a   Letendre, Scott L ^a   Grant, Igor ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84885646382     PISSN: 15403416     EISSN: 15410706     Source Type: Journal    
DOI: 10.1007/s11901-010-0085-8     Document Type: Review

References (50)

1. Laskus T, Radkowski M, Adair DM, et al.: Emerging evidence of hepatitis C virus neuroinvasion. AIDS 2005, 19(Suppl 3):S140-S144. (Pubitemid 41682182)
2. Perry W, Hilsabeck RC, Hassanein TI: Cognitive dysfunction in chronic hepatitis C: a review. Dig Dis Sci 2008, 53:307-321. (Pubitemid 351170036)
3. Forton DM, Taylor-Robinson SD, Thomas C: Central nervous system changes in hepatitis C virus infection. Eur J Gastroenterol Hepatol 2006, 18:333-338.
4. Laskus T, Radkowski M, Wang LF, et al.: Hepatitis C virus quasispecies in patients infected with HIV-1: correlation with extrahepatic viral replication. Virology 1998, 248:164-171. (Pubitemid 28393940)
5. Bolay H, Soylemezoglu F, Nurlu G, et al.: PCR detected hepatitis C virus genome in the brain of a case with progressive encephalomyelitis with rigidity. Clin Neurol Neurosurg 1996, 98:305-308. (Pubitemid 26382131)
6. Forton DM, Allsop JM, Main J, et al.: Evidence for a cerebral effect of the hepatitis C virus. Lancet 2001, 358:38-39. (Pubitemid 32709741)
7. Letendre S, Paulino AD, Rockenstein E, et al.: Pathogenesis of hepatitis C virus coinfection in the brains of patients infected with HIV. J Infect Dis 2007, 196:361-370. (Pubitemid 47093886)
8. Wilkinson J, Radkowski M, Laskus T: Hepatitis C virus neuroinvasion: identification of infected cells. J Virol 2009, 83:1312-1319.
9. Weissenborn K, Krausse J, Bokemeyer M, et al.: Hepatitis C virus infection affects the brain - evidence from psychometric studies and magnetic resonance spectroscopy. J Hepatol 2004, 41:845-851. (Pubitemid 39434316)
10. Taylor MJ, Letendre SL, Schweinsburg BC, et al.: Hepatitis C virus infection is associated with reduced white matter N-acetylaspartate in abstinent methamphetamine users. J Int Neuropsychol Soc 2004, 10:110-113. (Pubitemid 38128468)
11. Forton DM, Thomas HC, Murphy CA, et al.: Hepatitis C and cognitive impairment in a cohort of patients with mild liver disease. Hepatology 2002, 35:433-439. (Pubitemid 34106386)
12. McAndrews MP, Farcnik K, Carlen P, et al.: Prevalence and significance of neurocognitive dysfunction in hepatitis C in the absence of correlated risk factors. Hepatology 2005, 41:801-808. (Pubitemid 40462942)
13. Forton DM, Hamilton G, Allsop JM, et al.: Cerebral immune activation in chronic hepatitis C infection: a magnetic resonance spectroscopy study. J Hepatol 2008, 49:316-322.
14. Weissenborn K, Krause J, Bokemeyer M, et al.: Monoaminergic neurotransmission is altered in hepatitis C virus infected patients with chronic fatigue and cognitive impairment. Gut 2006, 55:1624-1630. (Pubitemid 44629214)
15. Weissenborn K, Tryc AB, Heeren M, et al.: Hepatitis C virus infection and the brain. Metab Brain Dis 2009, 24:197-210.
16. Burggren AC, Zeineh MM, Ekstrom AD, et al.: Reduced cortical thickness in hippocampal subregions among cognitively normal apolipoprotein E e4 carriers. Neuroimage 2008, 41:1177-1183.
17. Ernst T, Chang L, Arnold S: Increased glial metabolites predict increased working memory network activation in HIV brain injury. Neuroimage 2003, 19:1686-1693. (Pubitemid 37025864)
18. Fontana RJ, Bieliauskas LA, Back-Madruga C, et al.: Cognitive function in hepatitis C patients with advanced fibrosis enrolled in the HALT-C trial. J Hepatol 2005, 43:614-622. (Pubitemid 41253228)
19. Weissenborn K, Ennen JC, Schomerus H, et al.: Neuropsychological characterization of hepatic encephalopathy. J Hepatol 2001, 34:768-773. (Pubitemid 32488796)
20. Hilsabeck RC, Perry W, Hassanein TI: Neuropsychological impairment in patients with chronic hepatitis C. Hepatology 2002, 35:440-446. (Pubitemid 34106387)
21. Cordoba J, Flavia M, Jacas C, et al.: Quality of life and cognitive function in hepatitis C at different stages of liver disease. J Hepatol 2003, 39:231-238. (Pubitemid 36920559)
22. • Huckans M, Seelye A, Parcel T, et al.: The cognitive effects of hepatitis C in the presence and absence of a history of substance use disorder. J Int Neuropsychol Soc 2009, 15:69-82. This article describes one of the few studies directly assessing the effects of both HCV virus and substance abuse.
23. Kramer l, Bauer E, Funk G, et al.: Subclinical impairment of brain function in chronic hepatitis C infection. J Hepatol 2002, 37:349-354.
24. Ryan EL, Morgello S, Isaacs K, et al.: Neuropsychiatric impact of hepatitis C on advanced HIV. Neurology 2004, 62:957-962. (Pubitemid 38435785)
25. von Giesen HJ, Heintges T, Abbasi-Boroudjeni N, et al.: Psychomotor slowing in hepatitis C and HIV infection. J Acquir Immune Defic Syndr 2004, 35:131-137. (Pubitemid 38133735)
26. Letendre SL, Cherner M, Ellis RJ, et al.: Individuals co-infected with hepatitis C (HCV) and HIV are more cognitively impaired than those infected with either virus alone [abstract]. J Neurovirol 2002, 8:27-28.
27. Hinkin CH, Castellon SA, Levine AJ, et al.: Neurocognition in individuals co-infected with HIV and hepatitis C. J Addict Dis 2008, 27:11-17.
28. Wessely S, Pariante C: Fatigue, depression and chronic hepatitis C infection. Psychol Med 2002, 32:1-10. (Pubitemid 33150499)
29. Obhrai J, Hall Y, Anand BS: Assessment of fatigue and psychologic disturbances in patients with hepatitis C virus infection. J Clin Gastroenterol 2001, 32:413-417. (Pubitemid 32378274)
30. Fontana RJ, Hussain KB, Schwartz SM, et al.: Emotional distress in chronic hepatitis C patients not receiving antiviral therapy. J Hepatol 2002, 36:401-407. (Pubitemid 34194801)
31. Hilsabeck RC, Hassanein TI, Carlson MD, et al.: Cognitive functioning and psychiatric symptomatology in patients with chronic hepatitis C. J Int Neuropsychol Soc 2003, 9:847-854. (Pubitemid 37139014)
32. Kramer L, Bauer E, Funk G, et al.: Subclinical impairment of brain function in chronic hepatitis C infection. J Hepatol 2002, 37:349-354. (Pubitemid 34969951)
33. Vial T, Descotes J: Clinical toxicity of the interferons. Drug Saf 1994, 10:115-150. (Pubitemid 24045721)
34. van Gorp WG, Satz P, Hinkin C, et al.: Metacognition in HIV-1 seropositive asymptomatic individuals: self-ratings versus objective neuropsychological performance. Multicenter AIDS Cohort Study (MACS). J Clin Exp Neuropsychol 1991, 13:812-819.
35. Lieb K, Engelbrecht MA, Gut O, et al.: Cognitive impairment in patients with chronic hepatitis treated with interferon alpha (IFN alpha): results from a prospective study. Eur Psychiatry 2006, 21:204-210. (Pubitemid 44316600)
36. Pawelczyk T, Pawelczyk A, Strzelecki D, et al.: Pegylated interferon alpha and ribavirin therapy may induce working memory disturbances in chronic hepatitis C patients. Gen Hosp Psychiatry 2008, 30:501-508.
37. • Fontana RJ, Bieliauskas LA, Lindsay KL, et al.: Cognitive function does not worsen during pegylated interferon and ribavirin retreatment of chronic hepatitis C. Hepatology 2007, 45:1154-1163. This article describes the most comprehensive study assessing the effects on cognition of HCV treatment. (Pubitemid 46775777)
38. Thein H, Maruff P, Krahn M, et al.: Improved cognitive function as a consequence of hepatitis C virus treatment. HIV Med 2007, 8:520-528. (Pubitemid 47616831)
39. Lezak MD: Neuropsychological Assessment, edn 4. New York: Oxford University Press; 2004.
40. Bieliauskas LA, Back-Madruga C, Lindsay KL, et al.: Clinical relevance of cognitive scores in hepatitis C patients with advanced fibrosis. J Clin Exp Neuropsychol 2006, 28:1346-1361. (Pubitemid 44591898)
41. • Karaivazoglou K, Assimakopoulos K, Thomopoulos K, et al.: Neuropsychological function in Greek patients with chronic hepatitis C. Liver Int 2007, 27:798-805. This article describes one of the few studies comparing HCV-positive individuals with HBV-positive individuals. (Pubitemid 47062047)
42. Vigil O, Posada C, Woods SP, et al.: Impairments in fine-motor coordination and speed of information processing predict declines in everyday functioning in hepatitis C infection. J Clin Exp Neuropsychol 2008:1-11.
43. Tulving E: Episodic and semantic memory. In Organization of Memory. Edited by Tulving E, Donaldson W. Oxford, England: Academic Press; 1972.
44. Benedict RH, Schretlen D, Groninger L, Brandt J: Hopkins Verbal Learning Test-Revised: normative data and analysis of inter-form and test-retest reliability. Clin Neuropsychol 1998, 12:43-55. (Pubitemid 28168220)
45. Benedict RH: Brief Visuospatial Memory Test-Revised. Odessa, FL: Psychological Assessment Resources; 1997.
46. Moscovitch M: Cognitive resources and dual-task interference effects at retrieval in normal people: the role of the frontal lobes and medial temporal cortex. Neuropsychology 1994:524-534.
47. Spiegel BM, Younossi ZM, Hays RD, et al.: Impact of hepatitis C on health related quality of life: a systematic review and quantitative assessment. Hepatology 2005, 41:790-800. (Pubitemid 40462941)
48. Weiss JJ, Bräu N, Stivala A, et al.: Review article: adherence to medication for chronic hepatitis C - building on the model of human immunodeficiency virus antiretroviral adherence research. Aliment Pharmacol Ther 2009, 30:14-27.
49. Hinkin CH, Castellon SA, Durvasula RS, et al.: Medication adherence among HIV+ adults: effects of cognitive dysfunction and regimen complexity. Neurology 2002, 59:1944-1950. (Pubitemid 36076569)
50. Woods SP, Dawson MS, Weber E, et al.: Timing is everything: antiretroviral nonadherence is associated with impairment in time-based prospective memory. J Int Neuropsychol Soc 2009, 15:42-52.